Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.6, replacing the previous v3.6.5 and signaling a recent update to the record.
    Difference
    0.0%
    Check dated 2026-08-29T20:07:35.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.5, indicating a newer version of the site template or content management update.
    Difference
    0.0%
    Check dated 2026-08-08T16:59:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The site revision has been updated to v3.6.4, indicating a deployment update. No study data or page content is affected by this change.
    Difference
    0.0%
    Check dated 2026-07-25T09:31:25.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.2 to v3.6.3, indicating a minor site revision. This change reflects an update to the page's version tag rather than any alteration to the study content or details.
    Difference
    0.0%
    Check dated 2026-07-03T22:36:34.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page version. This does not alter trial data or visible content.
    Difference
    0.0%
    Check dated 2026-06-26T19:38:46.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants,' indicating that enrollment is closed. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label was standardized, with the revision notice updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:41:32.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.